ASCLD Emerging Drugs Task Force Update
نویسندگان
چکیده
منابع مشابه
An update on emerging drugs for Hodgkin lymphoma.
INTRODUCTION Most patients with Hodgkin lymphoma (HL) are cured with modern combined modality first-line treatments. Even ~ 50% of patients with relapsed/refractory HL can be cured with high-dose chemotherapy (HDCT) and autologous stem cell transplantation. However, chemotherapy and radiotherapy cause significant acute and long-term side effects and patients relapsing after HDCT have a dismal p...
متن کاملNLA Task Force on Statin Safety--2014 update.
1933-2874/$ see front matter 2014 http://dx.doi.org/10.1016/j.jacl.2014.03 Statins are the most widely prescribed class of medications in the United States and their benefits for lowering lowdensity lipoprotein cholesterol (LDL-C) and reducing the risk for coronary heart disease (CHD) are well documented. Statins have been the cornerstone of pharmacotherapy for the management of high blood chol...
متن کاملTask Force 9: drugs and performance-enhancing substances.
Athletes commonly use drugs and dietary supplements because they hope to improve athletic performance. These performance-enhancing substances include ergogenic and thermogenic supplements, stimulants, anabolic steroids, peptide hormones, and others. Despite aggressive marketing and user testimonials, scientific studies assessing the benefits and risks of any of these substances have not been co...
متن کاملEmerging antidyslipidemic drugs.
BACKGROUND Many patients at high risk for coronary heart disease (CHD) fail to reach target lipid levels with currently available medications, and a small but clinically relevant proportion of patients experience adverse effects. Thus, additional pharmaceutical strategies are required to fill these gaps in efficacy and tolerability. OBJECTIVE To provide an overview of both current and emergin...
متن کاملEmerging anticoagulant drugs.
The limitations of traditional anticoagulants, heparin and warfarin, have prompted the development of new anticoagulant drugs for prevention and treatment of both venous and arterial thromboembolism. After a brief review of thrombogenesis and its regulation, this study focuses on new anticoagulant agents in more advanced stages of clinical testing.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Forensic Science International: Synergy
سال: 2019
ISSN: 2589-871X
DOI: 10.1016/j.fsisyn.2019.06.042